These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4022499)

  • 21. Immunohistochemical staining for Ki-67 antigen, carcinoembryonic antigen, and p53 in the differential diagnosis of glandular lesions of the cervix.
    Cina SJ; Richardson MS; Austin RM; Kurman RJ
    Mod Pathol; 1997 Mar; 10(3):176-80. PubMed ID: 9071723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hormones and embryogenesis of the uterine cervix].
    Hoang-Ngoc Minh ; Smadja A; Remotti G
    Rev Fr Gynecol Obstet; 1993 Mar; 88(3):151-5. PubMed ID: 8493445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pathological findings as a consequence of intrauterine diethylstilbestrol (DES) exposure].
    Schujman E
    Harefuah; 1982 Nov; 103(9):211-3. PubMed ID: 7169191
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical evaluation of follow-up methods and results of atypical glandular cells of undetermined significance (AGUS) detected on cervicovaginal Pap smears.
    Kim TJ; Kim HS; Park CT; Park IS; Hong SR; Park JS; Shim JU
    Gynecol Oncol; 1999 May; 73(2):292-8. PubMed ID: 10329049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Therapy damage in gynecology. (Clinical observations of the effects of female sexual hormones and of compounds with similar action) (report) (author's transl)].
    Ober KG
    Verh Dtsch Ges Pathol; 1972; 56():283-91. PubMed ID: 4130830
    [No Abstract]   [Full Text] [Related]  

  • 26. A clinicopathologic study of vagina and cervix in DES-exposed progeny.
    Zerner J; Fu YS; Taxiarchis LN; Reagan JW; Richart RM
    Diagn Gynecol Obstet; 1980; 2(4):245-56. PubMed ID: 7215109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hormones and cardiovascular health in women.
    ESHRE Capri Workshop Group
    Hum Reprod Update; 2006; 12(5):483-97. PubMed ID: 16807276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microglandular hyperplasia: a pitfall in the diagnosis of microglandular type endometrioid adenocarcinoma.
    Da Forno PD; McGregor AH; Brown LJ
    Histopathology; 2005 Mar; 46(3):346-8. PubMed ID: 15720424
    [No Abstract]   [Full Text] [Related]  

  • 29. [Histological nomenclature and classification of benign epithelial changes in the cervix uteri and of pre- and early stages of cervix carcinoma].
    Büttner HH; Kyank H; Bader G
    Zentralbl Gynakol; 1974 Aug; 96(31):461-8. PubMed ID: 4471673
    [No Abstract]   [Full Text] [Related]  

  • 30. [The use of hormonal contraception in perimenopause is still a hazard?].
    Buttarelli M; Ghezzi F; Cromi A; Raio L; Franchi M
    Minerva Ginecol; 2001 Dec; 53(6):421-9. PubMed ID: 11723427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Micro-glandular hyperplasia of the cervix canal mucosa].
    Szczudrawa A; Bogdanowicz M; Pityński K; Czekaj A
    Ginekol Pol; 1993 Mar; 64(3):145-8. PubMed ID: 8359742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of morphologic and immunohistochemical features of cervical microglandular hyperplasia with low-grade mucinous adenocarcinoma of the endometrium.
    Qiu W; Mittal K
    Int J Gynecol Pathol; 2003 Jul; 22(3):261-5. PubMed ID: 12819393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Benign mucinous ovarian tumour with areas resembling microglandular hyperplasia of the cervix.
    Saurine T; Danieletto S; Prabhala G; Russell P
    Pathology; 2006 Feb; 38(1):87-9. PubMed ID: 16484021
    [No Abstract]   [Full Text] [Related]  

  • 34. Estrogens in oral contraceptives: historical perspectives.
    Goldzieher JW
    Johns Hopkins Med J; 1982 May; 150(5):165-9. PubMed ID: 7043034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of estrogens as a risk factor for stroke in postmenopausal women.
    Rosenberg SH; Fausone V; Clark R
    West J Med; 1980 Oct; 133(4):292-6. PubMed ID: 7347044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The effect of two contraceptive methods (EP vs. IUD) in relation to inflammatory changes and CIN].
    Cipolla L; Manzi P; Giannetta G; Ferrante B; Zagni R
    Minerva Ginecol; 1993 Jun; 45(6):315-20. PubMed ID: 8355888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Unintended effects of oral contraceptives. II. Progesterone-caused effects, interactions with drugs].
    Kopera H
    Wien Med Wochenschr; 1985 Sep; 135(17):415-9. PubMed ID: 3840624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of oral contraception on cytology and histology of the cervix uteri. Population screening for cervical carcinoma in Maribo amt 1967-1969.
    Berget A; Weber T
    Dan Med Bull; 1974 Aug; 21(5):172-6. PubMed ID: 4852441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clear cell adenocarcinoma of the cervix unrelated to diethylstilbestrol exposure.
    Kaminski PF; Maier RC
    Obstet Gynecol; 1983 Dec; 62(6):720-7. PubMed ID: 6633997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Personal observations concerning precancerous and cancerous lesions of the corpus uteri].
    Uyttenbroeck F
    Chirurgie; 1977 Feb; 103(2):122-9. PubMed ID: 872690
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.